Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C I Falkson

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Anti-Cancer Drugs|December 1, 1995
Treatment of metastatic malignant melanomaC I Falkson
Medical Oncology (Northwood, London, England)|March 1, 1995
Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanomaC I Falkson
American Journal of Clinical Oncology|June 1, 1996
Fludarabine: a phase II trial in patients with previously treated low-grade lymphomaC I Falkson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 26, 1985
Mesothelioma or ovarian carcinoma? A case reportC I Falkson
Oncology|November 5, 1999
A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinomaC I Falkson, G Falkson
Drugs|June 9, 1998
Current treatment options for malignant melanomaG L Cohen, C I Falkson
Oncology|March 14, 1998
Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary originC I Falkson, G L Cohen
Oncology|September 1, 1995
Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapyC I Falkson, H C Falkson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancerC I Falkson, H C Falkson
American Journal of Clinical Oncology|October 22, 1998
Extended survival in 80 patients with operable, locoregionally recurrent breast cancer treated with chemotherapyR W Eek, C I Falkson
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Anti-Cancer Drugs|December 1, 1995
Treatment of metastatic malignant melanomaC I Falkson
Medical Oncology (Northwood, London, England)|March 1, 1995
Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanomaC I Falkson
American Journal of Clinical Oncology|June 1, 1996
Fludarabine: a phase II trial in patients with previously treated low-grade lymphomaC I Falkson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 26, 1985
Mesothelioma or ovarian carcinoma? A case reportC I Falkson
Oncology|November 5, 1999
A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinomaC I Falkson, G Falkson
Drugs|June 9, 1998
Current treatment options for malignant melanomaG L Cohen, C I Falkson
Oncology|March 14, 1998
Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary originC I Falkson, G L Cohen
Oncology|September 1, 1995
Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapyC I Falkson, H C Falkson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancerC I Falkson, H C Falkson
American Journal of Clinical Oncology|October 22, 1998
Extended survival in 80 patients with operable, locoregionally recurrent breast cancer treated with chemotherapyR W Eek, C I Falkson
Pageof 5